Wednesday, March 29, 2023


Biotechnology News Magazine

Myonex Completes Acquisition of Hubertus Clinical Trial and Packaging Business

Latest Posts

Risk From Pharma Reps Using Unapproved Content and Messaging in the Field Persists, but a Focus on Training Could Be the Answer

ACTO advises Study Reveals 50% of respondents in leadership roles catch incidents of field reps using unapproved content, but a continuous learning culture could eliminate this behavior.

Entrinsic Bioscience® Expands enterade® Brand with Innovative Approach to the Dietary Support of Irritable Bowel Syndrome with Diarrhea (IBS-D

enterade® IBS-D is the first medical food formulated with plant-based amino acids and electrolytes for Irritable Bowel Syndrome with Diarrhea (IBS-D)-

Russell Finex Helps Leading Pharmaceutical Company Meet High Levels Of Demand With The Russell Compact Sieve

To ensure the highest quality final product, the company reached out to Russell Finex for a high-capacity vibrating screen. After assessing the company’s requirements, Russell Finex recommended the Russell Compact Sieve® as the ideal solution for check-screening pharmaceutical powders due to its stainless-steel contact parts, and easy-to-clean strip down design.

How Biotech Businesses Can Benefit from Freelance Experts

Ashmita Das, CEO of open talent platform Kolabtree, shares some of Kolabtree freelancer’s success stories.

Myonex, a leading global clinical trial supply company, announced today the completion of its acquisition of the clinical trial and packaging business of Hubertus Apotheke, located in Berlin, Germany. The new entity, Myonex GmbH, supports the company’s recent growth and strengthens its presence throughout the European Union.

“The new Berlin location strengthens our capabilities and resources inside the EU for both packaging and sourcing, including decentralized trials,” said James Lovett, Chief Executive Officer at Myonex. “In particular, our new German location can provide a range of packaging services, including secondary and primary packaging. Our experienced team in Berlin works with flexibility and efficiency to help our clients advance their development of new medicines.” The Berlin location will remain under the leadership of Stefan Dittmann, PhD, who will report to Markus Vogt, PhD., Myonex Vice President, Clinical Trial Packaging and Distribution.

Both companies originated as pharmacies more than 30 years ago, are privately owned, and share similar client-focused cultures. Hubertus has retained its pharmacy business for nonclinical trial business.

“We have been working diligently to streamline this transition for our partners and to make it virtually seamless for our customers,” said Dr. Vogt. “We are excited about all the ways our new capabilities can support all phases of their clinical trials.”

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine